Abstract
<b/> In this issue of Cancer Discovery, McKinney and colleagues describe the genetics of hepatosplenic T-cell lymphoma, a rare subtype of T-cell lymphoma with unique clinical characteristics. The findings, specifically frequent mutations of STAT5B, PIK3CD, and the histone methyltransferase SETD2, may help guide translational efforts to target this deadly disease. Cancer Discov; 7(4); 352-3. ©2017 AACR.See related article by McKinney et al., p. 369.
©2017 American Association for Cancer Research.
MeSH terms
-
Animals
-
Base Sequence / genetics
-
Class I Phosphatidylinositol 3-Kinases / genetics*
-
Exome / genetics
-
Genome, Human
-
Hepatomegaly / complications
-
Hepatomegaly / genetics
-
Hepatomegaly / pathology
-
Histone-Lysine N-Methyltransferase / genetics*
-
Humans
-
Lymphoma, T-Cell / complications
-
Lymphoma, T-Cell / genetics*
-
Lymphoma, T-Cell / pathology
-
Mice
-
STAT5 Transcription Factor / genetics*
-
Splenomegaly / complications
-
Splenomegaly / genetics
-
Splenomegaly / pathology
-
Xenograft Model Antitumor Assays
Substances
-
STAT5 Transcription Factor
-
STAT5B protein, human
-
Histone-Lysine N-Methyltransferase
-
SETD2 protein, human
-
Class I Phosphatidylinositol 3-Kinases
-
PIK3CD protein, human